MIC+B12 Injections contains a combination of methionine, inositol, choline, and vitamin B12 as the active ingredients, along with standard inactive ingredients used to support stability, accurate dosing, and injectable delivery
There are references to early-phase or investigator-initiated work in specific niches (such as inflammatory bowel conditions), but no robust, peer-reviewed, placebo-controlled human safety dataset has been widely published
Follow-up blood work is the clinical gold standard, and we typically re-test after a set number of injections to confirm your levels are rising into a healthy range
Retatrutide is expected to be commercially available in 2026 or 2027
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH)
Phosphate-Buffered Saline (PBS): Maintains stable physiological pH (approximately 7.4) with appropriate ionic strength